Kim Austin D.'s Insider Trades & SAST Disclosures
Kim Austin D.'s most recent trade in Acadia Pharmaceuticals Inc was a trade of 1,634 Restricted Stock Units done . Disclosure was reported to the exchange on Jan. 6, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Kim Austin D..To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Acadia Pharmaceuticals Inc | Kim Austin D. | EVP,General Counsel, Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2024 | 1,634 | 0 | - | - | Restricted Stock Units | |
| Acadia Pharmaceuticals Inc | Kim D. Austin | EVP,General Counsel, Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2024 | 1,634 | 47,491 (0%) | 0% | - | Common Stock | |
| Acadia Pharmaceuticals Inc | D. Kim Austin | EVP,General Counsel, Secretary | Sale of securities on an exchange or to another person at price $ 29.96 per share. | 06 Jan 2024 | 590 | 46,901 (0%) | 0% | 30.0 | 17,676 | Common Stock |
| Acadia Pharmaceuticals Inc | Austin D. Kim | EVP,General Counsel, Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2023 | 59,957 | 59,957 | - | - | Stock Options (Right to Buy) | |
| Acadia Pharmaceuticals Inc | Austin D. Kim | EVP,General Counsel, Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2023 | 18,172 | 18,172 | - | - | Restricted Stock Units | |
| Acadia Pharmaceuticals Inc | Austin D. Kim | EVP,General Counsel, Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Apr 2023 | 3,005 | 0 | - | - | Restricted Stock Units | |
| Acadia Pharmaceuticals Inc | Austin D. Kim | EVP,General Counsel, Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Apr 2023 | 3,005 | 26,430 (0%) | 0% | - | Common Stock | |
| Acadia Pharmaceuticals Inc | Austin D. Kim | EVP,General Counsel, Secretary | Sale of securities on an exchange or to another person at price $ 21.18 per share. | 29 Apr 2023 | 917 | 25,513 (0%) | 0% | 21.2 | 19,422 | Common Stock |
| Acadia Pharmaceuticals Inc | Austin D. Kim | EVP,General Counsel, Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Apr 2023 | 4,773 | 14,319 | - | - | Restricted Stock Units | |
| Acadia Pharmaceuticals Inc | Austin D. Kim | EVP,General Counsel, Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Apr 2023 | 4,773 | 24,881 (0%) | 0% | - | Common Stock | |
| Acadia Pharmaceuticals Inc | Austin D. Kim | EVP,General Counsel, Secretary | Sale of securities on an exchange or to another person at price $ 18.16 per share. | 05 Apr 2023 | 1,456 | 23,425 (0%) | 0% | 18.2 | 26,441 | Common Stock |
| Acadia Pharmaceuticals Inc | Austin D. Kim | EVP,General Counsel, Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2023 | 2,214 | 20,911 (0%) | 0% | - | Common Stock | |
| Acadia Pharmaceuticals Inc | Austin D. Kim | EVP,General Counsel, Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2023 | 2,214 | 4,428 | - | - | Restricted Stock Units | |
| Acadia Pharmaceuticals Inc | Austin D. Kim | EVP,General Counsel, Secretary | Sale of securities on an exchange or to another person at price $ 18.78 per share. | 23 Feb 2023 | 803 | 20,108 (0%) | 0% | 18.8 | 15,080 | Common Stock |
| Acadia Pharmaceuticals Inc | Austin D. Kim | EVP,General Counsel, Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2023 | 1,633 | 19,286 (0%) | 0% | - | Common Stock | |
| Acadia Pharmaceuticals Inc | Austin D. Kim | EVP,General Counsel, Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2023 | 1,633 | 1,634 | - | - | Restricted Stock Units | |
| Acadia Pharmaceuticals Inc | Austin D. Kim | EVP,General Counsel, Secretary | Sale of securities on an exchange or to another person at price $ 17.13 per share. | 06 Jan 2023 | 589 | 18,697 (0%) | 0% | 17.1 | 10,090 | Common Stock |
| Acadia Pharmaceuticals Inc | Austin D. Kim | EVP,General Counsel, Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Apr 2022 | 3,005 | 3,005 | - | - | Restricted Stock Units | |
| Acadia Pharmaceuticals Inc | Austin D. Kim | EVP,General Counsel, Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Apr 2022 | 3,005 | 17,636 (0%) | 0% | - | Common Stock | |
| Acadia Pharmaceuticals Inc | Austin D. Kim | EVP,General Counsel, Secretary | Sale of securities on an exchange or to another person at price $ 18.18 per share. | 29 Apr 2022 | 894 | 16,742 (0%) | 0% | 18.2 | 16,255 | Common Stock |
| Acadia Pharmaceuticals Inc | Austin D. Kim | EVP,General Counsel, Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Apr 2022 | 96,463 | 96,463 | - | - | Restricted Stock Units | |
| Acadia Pharmaceuticals Inc | Austin D. Kim | EVP,General Counsel, Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Apr 2022 | 65,517 | 65,517 | - | - | Stock Options (Right to Buy) | |
| Acadia Pharmaceuticals Inc | Austin D. Kim | EVP,General Counsel, Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Apr 2022 | 19,092 | 19,092 | - | - | Restricted Stock Units | |
| Acadia Pharmaceuticals Inc | Austin D. Kim | EVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2022 | 2,213 | 15,413 (0%) | 0% | 0 | Common Stock | |
| Acadia Pharmaceuticals Inc | Austin D. Kim | EVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2022 | 2,213 | 6,642 | - | - | Restricted Stock Units | |
| Acadia Pharmaceuticals Inc | Austin D. Kim | EVP & General Counsel | Sale of securities on an exchange or to another person at price $ 23.80 per share. | 23 Feb 2022 | 782 | 14,631 (0%) | 0% | 23.8 | 18,612 | Common Stock |
| Acadia Pharmaceuticals Inc | Austin D. Kim | EVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2022 | 1,633 | 13,774 (0%) | 0% | - | Common Stock | |
| Acadia Pharmaceuticals Inc | Austin D. Kim | EVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2022 | 1,633 | 3,267 | - | - | Restricted Stock Units | |
| Acadia Pharmaceuticals Inc | Austin D. Kim | EVP & General Counsel | Sale of securities on an exchange or to another person at price $ 23.05 per share. | 06 Jan 2022 | 574 | 13,200 (0%) | 0% | 23.1 | 13,231 | Common Stock |
| Acadia Pharmaceuticals Inc | Austin D. Kim | EVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Apr 2021 | 3,005 | 6,010 | - | - | Restricted Stock Units | |
| Acadia Pharmaceuticals Inc | Austin D. Kim | EVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Apr 2021 | 3,005 | 12,425 (0%) | 0% | - | Common Stock | |
| Acadia Pharmaceuticals Inc | Austin D. Kim | EVP & General Counsel | Sale of securities on an exchange or to another person at price $ 20.33 per share. | 29 Apr 2021 | 1,054 | 11,371 (0%) | 0% | 20.3 | 21,428 | Common Stock |
| Acadia Pharmaceuticals Inc | Austin D. Kim | EVP & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2021 | 32,608 | 32,608 | - | - | Stock Options (Right to Buy) | |
| Acadia Pharmaceuticals Inc | Austin D. Kim | EVP & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2021 | 8,855 | 8,855 | - | - | Restricted Stock Units | |
| Acadia Pharmaceuticals Inc | Austin D. Kim | EVP & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2021 | 6,009 | 12,018 (0%) | 0% | 0 | Common Stock | |
| Acadia Pharmaceuticals Inc | Austin D. Kim | EVP & General Counsel | Sale of securities on an exchange or to another person at price $ 50.61 per share. | 04 Feb 2021 | 2,107 | 9,911 (0%) | 0% | 50.6 | 106,635 | Common Stock |
| Acadia Pharmaceuticals Inc | Austin D. Kim | EVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2021 | 1,633 | 6,196 (0%) | 0% | - | Common Stock | |
| Acadia Pharmaceuticals Inc | Austin D. Kim | EVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2021 | 1,633 | 4,900 | - | - | Restricted Stock Units | |
| Acadia Pharmaceuticals Inc | Austin D. Kim | EVP & General Counsel | Sale of securities on an exchange or to another person at price $ 53.34 per share. | 06 Jan 2021 | 678 | 5,518 (0%) | 0% | 53.3 | 36,165 | Common Stock |
| Acadia Pharmaceuticals Inc | Austin D. Kim | EVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.58 per share. | 27 Oct 2020 | 8,750 | 12,601 (0%) | 0% | 17.6 | 153,825 | Common Stock |
| Acadia Pharmaceuticals Inc | Austin D. Kim | EVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Oct 2020 | 8,750 | 113,750 | - | - | Stock Option (Right to Buy) | |
| Acadia Pharmaceuticals Inc | Austin D. Kim | EVP & General Counsel | Sale of securities on an exchange or to another person at price $ 45.10 per share. | 27 Oct 2020 | 8,750 | 3,851 (0%) | 0% | 45.1 | 394,636 | Common Stock |
| Acadia Pharmaceuticals Inc | Austin D. Kim | EVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Apr 2020 | 3,004 | 9,015 | - | - | Restricted Stock Units | |
| Acadia Pharmaceuticals Inc | Austin D. Kim | EVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Apr 2020 | 3,004 | 3,513 (0%) | 0% | - | Common Stock | |
| Acadia Pharmaceuticals Inc | Austin D. Kim | EVP & General Counsel | Sale of securities on an exchange or to another person at price $ 49.22 per share. | 29 Apr 2020 | 1,072 | 2,441 (0%) | 0% | 49.2 | 52,764 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges